Cofoe Medical Technology Co.,Ltd. (SHE:301087)
China flag China · Delayed Price · Currency is CNY
37.50
-0.34 (-0.90%)
At close: Aug 8, 2025, 2:57 PM CST

Cofoe Medical Technology Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2018 - 2020
7,6277,1927,7917,60612,626-
Upgrade
Market Cap Growth
1.90%-7.68%2.43%-39.76%--
Upgrade
Enterprise Value
5,8825,4605,8615,33712,682-
Upgrade
Last Close Price
37.5034.1134.8132.6952.66-
Upgrade
PE Ratio
25.5423.0730.6425.2129.44-
Upgrade
PS Ratio
2.622.412.732.565.55-
Upgrade
PB Ratio
1.551.501.591.512.54-
Upgrade
P/TBV Ratio
1.781.711.761.682.69-
Upgrade
P/FCF Ratio
19.6013.25378.22---
Upgrade
P/OCF Ratio
13.9910.8419.7876.8952.61-
Upgrade
EV/Sales Ratio
2.021.832.051.795.57-
Upgrade
EV/EBITDA Ratio
13.0613.2819.9418.2628.20-
Upgrade
EV/EBIT Ratio
20.6217.6327.8721.2430.13-
Upgrade
EV/FCF Ratio
15.1110.06284.55---
Upgrade
Debt / Equity Ratio
0.160.190.130.090.050.29
Upgrade
Debt / EBITDA Ratio
1.771.921.851.320.480.60
Upgrade
Debt / FCF Ratio
2.041.6631.11--2.37
Upgrade
Asset Turnover
0.450.470.450.490.601.67
Upgrade
Inventory Turnover
2.282.272.873.642.943.89
Upgrade
Quick Ratio
2.272.242.702.835.741.07
Upgrade
Current Ratio
2.892.883.533.546.621.71
Upgrade
Return on Equity (ROE)
6.12%6.43%5.09%6.04%14.40%53.09%
Upgrade
Return on Assets (ROA)
2.77%3.06%2.08%2.57%6.92%20.64%
Upgrade
Return on Capital (ROIC)
3.12%3.44%2.38%2.94%8.11%30.12%
Upgrade
Return on Capital Employed (ROCE)
5.60%6.10%4.10%4.80%8.20%44.30%
Upgrade
Earnings Yield
3.96%4.33%3.26%3.97%3.40%-
Upgrade
FCF Yield
5.10%7.55%0.26%-7.11%-2.16%-
Upgrade
Dividend Yield
4.76%5.28%3.45%3.67%2.34%-
Upgrade
Payout Ratio
124.09%120.12%98.28%86.05%0.63%7.72%
Upgrade
Buyback Yield / Dilution
-0.09%-0.46%1.70%-26.56%-5.47%-0.08%
Upgrade
Total Shareholder Return
4.70%4.82%5.15%-22.89%-3.13%-0.08%
Upgrade
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.